Changeflow GovPing Pharma & Drug Safety EP3283091A1 - Berry Extraction Method Using Alk...
Routine Rule Added Final

EP3283091A1 - Berry Extraction Method Using Alkaline Magnesium Compound

Favicon for changeflow.com EPO Patent Bulletin - Pharma (A61K)
Published
Detected
Email

Summary

The European Patent Office granted Patent EP3283091A1 to inventor Reijonen, Mika Tapio. The patent covers a method of extracting berries or fruits using an alkaline magnesium compound for use in pharmaceutical, herbal, nutritional, or cosmetic ingredients. The patent is valid in 38 designated European states.

Published by EPO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

The European Patent Office published Patent EP3283091A1 granting exclusive rights to Reijonen, Mika Tapio for a method of extracting berries or fruits using alkaline magnesium compounds. The patent covers applications in pharmaceutical, herbal, nutritional, and cosmetic ingredient formulations.\n\nManufacturers and companies developing extraction processes for berry-based or fruit-based ingredients should conduct freedom-to-operate analyses before commercializing similar methods. Competitors seeking alternative extraction techniques may need to design around this patent or pursue licensing arrangements with the patent holder.

What to do next

  1. Monitor patent family for related applications
  2. Review freedom-to-operate before commercializing similar extraction methods

Archived snapshot

Apr 16, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← EPO Patent Bulletin

METHOD OF EXTRACTION OF BERRIES OR FRUITS USING AN ALKALINE MAGNESIUM COMPOUND FOR PHARMACEUTICAL, HERBAL, NUTRITIONAL OR COSMETIC INGREDIENTS

Publication EP3283091A1 Kind: A1 Apr 08, 2026

Applicants

Reijonen, Mika Tapio

Inventors

Reijonen, Mika Tapio

IPC Classifications

A61K 36/18 20060101AFI20190117BHEP A61K 36/185 20060101ALI20190117BHEP A61K 8/97 20170101ALI20190117BHEP A61K 131/00 20060101ALI20190117BHEP A23L 19/00 20160101ALI20190117BHEP B01D 11/02 20060101ALI20190117BHEP A23L 5/40 20160101ALI20190117BHEP A23L 2/04 20060101ALI20190117BHEP A23L 2/52 20060101ALI20190117BHEP A61K 36/87 20060101ALI20190117BHEP A23L 33/105 20160101ALI20190117BHEP A61K 8/9783 20170101ALI20190117BHEP

Designated States

AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR

View original document →

Get daily alerts for EPO Patent Bulletin - Pharma (A61K)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from EPO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
EPO
Published
April 8th, 2026
Instrument
Rule
Legal weight
Binding
Stage
Final
Change scope
Minor
Document ID
EP3283091A1

Who this affects

Applies to
Manufacturers Pharmaceutical companies Healthcare providers
Industry sector
3254 Pharmaceutical Manufacturing
Activity scope
Patent granting Extraction method IP
Geographic scope
European Union EU

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Pharmaceuticals Food Safety

Get alerts for this source

We'll email you when EPO Patent Bulletin - Pharma (A61K) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!